Lung Cancer Genetic Mutation Linked to Higher Risk
A specific genetic mutation has been found to increase lung cancer risk significantly in carriers.
Updated on Sept. 18, 2026 in Cancer
Live Poll
If you knew you had a high genetic risk for cancer, would you seek regular screenings?
Researchers identified a link between the EGFR T790M genetic mutation and a drastically increased risk of lung cancer. The findings provide new insight for individuals carrying this rare variant as they manage their long-term health.
Why it matters
Identifying specific genetic predispositions allows for more precise risk assessment and may help tailor screening strategies for those at heightened risk. This discovery offers a clearer understanding of non-tobacco-related lung cancer development.
A study analyzing 3.3 million genotyped samples found that carriers of the EGFR T790M mutation face a 62-fold higher risk of lung cancer than non-smokers without the variant. This mutation appears in 1 in 15,850 participants, with a higher frequency of 1 in 8,920 among specific ancestries.
The players
American Cancer Society
A national health organization that provides data on cancer diagnoses and promotes research to reduce cancer mortality.
The details
The EGFR T790M mutation affects the epidermal growth factor receptor, a protein that plays a critical role in cell growth and division. When this gene is mutated, it can drive the uncontrolled cellular proliferation associated with malignancy. By tracing the historical migration of this variant, researchers identified that it originated in Europe before reaching the Southern Appalachian region two centuries ago.
Timeline
1826: The EGFR T790M mutation arrived in the Southern Appalachian region.
2026: The study results were published in the journal Science.
Health Landscape
This study advances the field of precision oncology by linking a specific mutation to a high, quantifiable increase in lung cancer risk. It updates the medical community's understanding of hereditary factors, which remains a secondary concern compared to the 80 percent of lung cancer deaths linked to smoking.
While smoking remains the primary driver of lung cancer, individuals with a strong family history of the disease should discuss potential genetic testing with their physician. These findings aim to eventually help doctors better identify who should undergo regular CT screening.
The takeaway
The EGFR T790M mutation is a significant genetic indicator for lung cancer risk that operates independently of tobacco use. If you have a family history of lung cancer, consider speaking with your doctor to determine if genetic counseling or advanced screening is appropriate for you.
Further reading
For more information on screening guidelines and risk factors, visit our Cancer section.
More information
Review the Science journal study on mutation for full methodology.
Live Poll
If you knew you had a high genetic risk for cancer, would you seek regular screenings?
